Working plan and methods

Initial study (first year)
We will initially focus on the mucus of the fish skin. The mucus is a first-line of defense against the surrounding environment, and interesting bioactive compounds have previously been detected in the mucus from several fish species (Rajanbabu and Chen, 2011) . We will make a comparative study of the three species using mass spectrometry (MS) and other proteomic tools to identify as many potentially bioactive compounds as possible.
Identification
As outlined in the figure the bioprospecting pathway includes sampling the mucus and filtration of samples resulting in two initial fractions. Low molecular weight fractions will be directly analyzed by LC-MS/MS. High molecular weight fractions will be subfractionated by isoelectric focusing in a gel free system (Agilent OffGel) and further by polyacrylamide electrophoresis. Detected proteins will be digested with trypsin and analyzed by LC-MS/MS.
Identification of peptides will first be done by searches against available genome and EST databases. Non-identified peptides with good spectra will be analyzed manually. Some low-molecular weight compounds that are not standard peptides (i.e., do not contains the standard unmodified amino acids) can have biological activities (Falkenberg et al., 2011) . These compounds might contain modified amino acids, or they might be other classes of molecules. By MS analysis of exact mass together with the isotopic peak distribution of the molecules we will be able to approach the chemical formulas.
Bioactivities
As for investigation of the antibacterial activities, we will first concentrate on the low molecular weight fractions (Rajanbabu and Chen, 2011) . The fractions will be tested with a standard bacterial growth assay using OD measurements. We also aim at developing two alternative bacterial assays. The simplest is an assay with poor bacterial growth conditions. Bacteria are much less sensitive to antibiotics under poor growth conditions (Eng et al., 1991; Nguyen et al., 2011) . Thus, fractions that can kill off bacteria under poor growth conditions are even more interesting. The other assay takes into account that the environment usually contains a mixture of bacteria. We will combine a metagenomic approach for testing of anti-bacterial effects, and investigate if certain bacteria are susceptible to the antibacterial effects while other bacteria are resistant.
Later studies (second and third year)
In the first year studies, we will hopefully have detected bioactivities. The main aim is now to identify the compounds that possess these activities. We will then concentrate on the species that have shown the highest measurable bioactivities in its mucus, and we must develop methods to obtain larger amounts of the mucus. More detailed fractionations will be needed. The initial fractionation methods will be by molecular weight (using filtration, dialysis, size exclusion chromatography, etc.) and by physicochemical properties (preparative HPLC using reverse phase chromatography, ion exchange chromatography, etc.). The results will be analyzed statistically by multivariate analysis and principal component analysis in support of the search for the bioactive compounds.
In cooperation with the Department of Food Science, Aarhus University, it is possible to test for antibacterial and/or immunomodulatory activity using in situ pig intestinal microbial survival model and in vivo infection model. The former model uses the natural intestinal flora of pigs. Immediately after killing a pig the proximal small intestine is exposed, sutured at 10 cm intervals, and cut to preserve intestinal content and saline. Peptides are added and the intestinal "bags" are incubated a couple of hours. The content is added to bacterial growth media and plated for counting of colonies the next day. The in vivo infection model uses weaned piglets of a certain genotype that is susceptible to infection with the E. coli strain HB104. The piglets will receive the test material and will subsequently be inoculated with the E. coli strain. Growth of E. coli HB104 and diarrhea will be scored.
Future studies (four to ten years +)
When the structures of the bioactive compounds are at hand, it can be determined whether the best approach for making industrial scale amounts of the compounds are by processing the secondary products from the fish industry, or by synthetic chemistry. Commercialization will be attempted if the compounds are promising. Furthermore, having established the necessary methods and competence, more complex starting materials can be entered into the bioprospecting pathway.
Figures Expected results and effects
We expect that there should be some differences between bottom-dwelling and pelagic species, as they probably have to be protected against partially different microbial and parasitic environments.
Through the work described here, we expect to isolate bioactive compounds, most likely with anti-bacterial activities, from the mucus of fish. The most potent compounds will be structurally determined, and commercialization will be attempted. Furthermore, a thorough characterization of mucus from salmon will also be a cornerstone in the fight against salmon (sea) louse (Lepeophtheiris salmonis).
Supported by
The detected proteins will be digested with trypsin.
High molecular weight fractions (>10 kDa) will be separated by isoelectric focusing.
The fractions will be further separated by polyacrylamide electrophoresis.
Low molecular weight fractions (<10 kDa) will be directly analysed by LC-MS/MS. High molecular weight fractions (>10 kDa) will be analysed by LC-MS/MS after separation and digestion.
Characterization and/or identification
Later studies Cod is among the most important catches of wild fish in the North Atlantic region. A proteomic study is available for cod mucus (Rajan et al., 2011) , and some antimicrobial peptides have been found in cod (Bergsson et al., 2005; Ruangsri et al., 2010) . The cod genome is available (Star et al., 2011) . In cod, some of the immune elements, which in other species participate in defense against infections, are lost (Star et al., 2011) .
Monkfish is a bottom-dwelling fish, and thus is more or less in constant contact with sea bed microflora, and might be expected to have a strong antimicrobial defense in their mucus. Anecdotes in the Faroe Islands suggest that mucus from monkfish may help wound healing.
Salmon is the most important farmed fish in the Northern Atlantic region. An incomplete proteomic reference is available for salmon mucus (Easy and Ross, 2009 ). Antibacterial peptides have been detected in salmon mucus (Luders et al., 2005; Narvaez et al., 2010) . Salmon louse (Lepeophtheiris salmonis) attach to the skin of the fish and appear to change the mucus protein composition (Easy and Ross, 2009) .
Preliminary study will involve three individuals of each species and four samples will be taken from each fish. Mucus is scraped off the right and left side of the dorsal fin, and from the left and right side between the pectoral and pelvic fins using sterile glass slides. In this way, we can compare the constitution of the dorsal and ventral mucus between the three species.
Filtration by Centricon filters 10 kDa cutoff resulting in two fractions.
Bioactivities
Low molecular weight fractions (<10 kDa) will be directly analyzed by standard bacterial growth assay, an assay with poor bacterial growth conditions and by a metagenomic assay. 
